Published in Blood Weekly, August 11th, 1997
The genetic manipulation of grafts, in particular cellular grafts such as islets, before transplantation represents a therapeutic approach for enhancing islet graft survival. Although ex vivo gene therapy techniques have received recent attention, this method is limited by the efficiency of gene transfer techniques.
Islet cells are organized like a 'miniorgan' and do not replicate. As a result, the standard techniques such as cationic liposome-mediated transfection, calcium phosphate co-precipitation, or retroviral infection are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.